Macrosomia, Fetal
15
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.7%
1 terminated out of 15 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (15)
Artificial Intelligence and Gestacional Diabetes
New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.
Lifestyle Intervention in Preparation for Pregnancy (LIPP)
Improving Patient Understanding of Macrosomia
Fetal Clavicular Measurement to Predict Fetal Macrosomia
Association Between Labor Induction and Birth Weight in Cases of Fetal Macrosomia: The MACROMODA Cohort Study
The Effect of Individualized Exercise Guidance on Pregnancy Outcome
the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome
Late Gestational Diabetes Mellitus Diagnosis in Obese Women
A First Trimester Prediction Model for Large for Gestational Age Infants: a Preliminary Study
To Evaluate the Efficacy and Safety of Balloon Catheter Combined With Oxytocin Induction in Nulliparous Women With Estimated Fetal Weight ≥3500g at 39-40 Weeks of Gestation
Effect of Tahneek on Hypoglycemia in Newborn Infants
Antenatal Development Evaluated Prospectively
Early Term Delivery Versus Expectant Management of the Large for Gestational Age Fetus
The DNA Methylation of ARHGEF11 in Macrosomia